|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-2.43/--
|
企業價值
4.80B
|
資產負債 |
每股賬面淨值
-3.34
|
現金流量 |
現金流量率
--
|
損益表 |
收益
91.43M
|
每股收益
0.23
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/20 13:45 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world byimproving access to proven treatments for various diseases. |